Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Investments

Latest From Investments

US start-up receives investment for gene editing canine cancer treatment

Iowa-based LifEngine Animal Health Laboratories (LEAH) has received a seed investment to support development of canine B cell lymphoma treatment. 

Canine Investments

M-AAA to invest $2.6m to tackle animal health challenges

The Michigan Alliance for Animal Agriculture (M-AAA) will invest $2.6 million in 2019 to confront a range of challenges that affect the animal agriculture industries.

Food Animals United States

Zomedica raises $4.28m at close of offering

Zomedica Pharmaceuticals has closed its private offering and raised proceeds of $4.28 million.
Investments Diagnostics

US start-up bags $50m funding for RNA capabilities with animal health potential

GreenLight Biosciences will support the development of RNA solutions for the agricultural and pharmaceutical industries with $50 million of funding.


Re-scheduled Animal Pharm investment webinar to air next week

Animal Pharm is teaming up with Kisaco Research to host a webinar dedicated to investment in the animal health industry. 

Investments Deals

Canada funds PRRS, needle-free swine vaccination projects

The governments of Canada and Quebec are backing two swine health and welfare projects.

Investments R&D
See All